Japanese (NIKKEI) Healthcare Sector Analysis
- 7D-1.6%
- 3M-13.8%
- 1Y-16.8%
- YTD-9.8%
Over the last 7 days, the Healthcare industry has dropped 1.5%, driven by a pullback from Shionogi of 7.3%. Meanwhile, Olympus actually outperformed within the industry, gaining 6.4% in the last week. However, the industry is down 17% over the past year.
Sector Valuation and Performance
Has the Japanese Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE |
|---|---|---|---|---|
| Tue, 25 Jan 2022 | JPÂ¥58.5t | JPÂ¥30.3t | JPÂ¥2.4t | 16.9x |
| Thu, 23 Dec 2021 | JPÂ¥63.4t | JPÂ¥30.3t | JPÂ¥2.4t | 17.4x |
| Sat, 20 Nov 2021 | JPÂ¥66.5t | JPÂ¥30.3t | JPÂ¥2.4t | 19x |
| Mon, 18 Oct 2021 | JPÂ¥68.0t | JPÂ¥29.7t | JPÂ¥2.2t | 20.4x |
| Wed, 15 Sep 2021 | JPÂ¥70.8t | JPÂ¥29.5t | JPÂ¥2.2t | 20.7x |
| Fri, 13 Aug 2021 | JPÂ¥65.1t | JPÂ¥29.5t | JPÂ¥2.2t | 20.3x |
| Tue, 08 Jun 2021 | JPÂ¥63.5t | JPÂ¥28.7t | JPÂ¥2.0t | 20.9x |
| Mon, 01 Mar 2021 | JPÂ¥64.3t | JPÂ¥28.6t | JPÂ¥1.8t | 22.7x |
| Thu, 03 Dec 2020 | JPÂ¥68.3t | JPÂ¥28.5t | JPÂ¥1.7t | 24.8x |
| Sun, 06 Sep 2020 | JPÂ¥63.2t | JPÂ¥28.6t | JPÂ¥1.8t | 24.2x |
| Wed, 10 Jun 2020 | JPÂ¥63.9t | JPÂ¥28.9t | JPÂ¥1.8t | 22.2x |
| Tue, 03 Mar 2020 | JPÂ¥52.8t | JPÂ¥28.7t | JPÂ¥1.8t | 19.5x |
| Fri, 06 Dec 2019 | JPÂ¥56.2t | JPÂ¥28.3t | JPÂ¥1.8t | 22.8x |
| Mon, 09 Sep 2019 | JPÂ¥48.0t | JPÂ¥27.4t | JPÂ¥1.8t | 20.8x |
| Sun, 02 Jun 2019 | JPÂ¥46.9t | JPÂ¥26.8t | JPÂ¥1.8t | 20.3x |
| Wed, 06 Mar 2019 | JPÂ¥50.5t | JPÂ¥26.2t | JPÂ¥1.7t | 22.6x |
20.4x
Current Industry PE: Investors are more pessimistic on the industry, considering it's trading at a PE ratio of 16.5x which is lower than its 3-year average PE of 21.6x. It appears they believe that earnings will not grow as fast as they have historically.
Past Earnings Growth: The earnings for companies in the Healthcare industry have grown 14% per year over the last three years, and revenues for these companies have grown 4.9% per year. This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Japanese Healthcare sector?
| Healthcare Services | -0.78% | |
| Pharma | -1.03% | |
| Healthtech | -1.46% | |
| Medical Equipment | -2.39% | |
| Life Sciences | -2.98% | |
| Biotech | -6.43% | |
Industry PE: Investors are most optimistic about the Healthtech industry even though it's trading below its 3-year average PE ratio of 63.2x. However analysts are expecting annual earnings growth of 12%, which is lower than the prior year's growth of 76% per year. So the market might believe that analysts are underestimating future growth. Meanwhile, investors are most pessimistic about the Medical Equipment industry, which is trading below its 3-year average of 22.5x.
Forecasted Growth: Analysts are most optimistic on the Life Sciences industry, expecting annual earnings growth of 33% over the next 5 years. However this is lower than its past earnings growth rate of 187% per year. Meanwhile, the Healthcare Services industry is expected to see its earnings grow by 6.7% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 7733 Olympus | JPÂ¥2.44k | 4.6% +JPÂ¥136.8b | 22.9% | PE30.7x | |
| 4519 Chugai Pharmaceutical | JPÂ¥3.70k | 1.7% +JPÂ¥101.9b | -33.9% | PE23.7x | |
| 4503 Astellas Pharma | JPÂ¥1.94k | 2.4% +JPÂ¥85.2b | 11.4% | PE30.1x | |
| 4568 Daiichi Sankyo Company | JPÂ¥2.61k | 1.5% +JPÂ¥74.8b | -26.2% | PE57.6x | |
| 4578 Otsuka Holdings | JPÂ¥4.20k | 3.1% +JPÂ¥69.4b | -7.5% | PE15.5x |